We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Steris Ltd (STE) Ord USD75.00

Sell:$208.83 Buy:$209.23 Change: $1.05 (0.51%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.05 (0.51%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $1.05 (0.51%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

STERIS plc is a provider of infection prevention and other procedural products and services. The Company offers a mix of consumable products, such as detergents, gastrointestinal (GI) endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair solutions, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (OR) integration. The Company operates through four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Its Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms, endoscopy suites, and renal dialysis centers.

Contact details

Block a Riverside IV
70 Sir John Rogerson's Quay
+353 (1) 2322000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$20.81 billion
Shares in issue:
100.08 million
Health Care Equipment
New York Stock Exchange
US dollar

Key personnel

  • Daniel Carestio
    President, Chief Executive Officer, Director
  • Michael Tokich
    Chief Financial Officer, Senior Vice President
  • Mary Fraser
    Chief Human Resource Officer, Vice President
  • John Zangerle
    Senior Vice President, General Counsel, Secretary
  • Andrew Xilas
    Senior Vice President, General Manager - Dental
  • Julia Madsen
    Senior Vice President - Life Sciences
  • Cary Majors
    Senior Vice President - Americas Commercial Operations
  • Karen Burton
    Chief Accounting Officer, Vice President, Controller
  • Renato Tamaro
    Vice President and Corporate Treasurer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.